
The zzso zzso has frequently been found activated in human zzso We show that in addition to zzso signaling dysfunction, the zzso zzso is often zzso in mouse zzso initiated zzso zzso zzso is a dual zzso inhibitor toxic to many cancer cell lines and currently involved in clinical zzso We have treated two mouse models involving zzso that develop small zzso and/or zzso tumors with zzso and a subset of animals with zzso and zzso inhibitor zzso The disease zzso has been followed with pathology, zzso zzso PET imaging, and zzso zzso zzso are significantly decreased in zzso by both drug zzso The majority of tumors treated with combined therapy zzso significantly, while a small number of highly progressed tumors zzso We have examined zzso zzso zzso zzso zzso zzso zzso zzso and zzso D1 and find variable zzso that include zzso of zzso zzso of zzso and changes in its zzso forms, zzso of zzso zzso zzso zzso and zzso zzso zzso has been found intact in some tumors and not in zzso Our data indicate that zzso alone and in combination with zzso are effective in treating a proportion of zzso zzso but that highly progressed resistant tumors grow in the presence of the zzso Pathways zzso in some resistant tumors also include zzso suggesting that zzso zzso may also be useful in treating these zzso 

